About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Linkage to Care - Part I | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT00703040

Linkage to Care - Part I

This first phase of a two-phase study involves three components: 1. Review of existing linkage-to-care protocols and sources of referrals for care; 2. Semi-structured telephone or face-to-face interv...

Lead sponsor: University of North Carolina, Chapel Hill•7 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

University of North Carolina, Chapel Hill

Collaborators

National Institute on Drug Abuse (NIDA)
National Institute of Mental Health (NIMH)

Age

All ages

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Component 1: Documents identified by clinical site personnel as pertaining to post-test counseling, linkage to care, or standard operating procedures addressing post-test counseling and linkage to care.
•Component 2: Persons employed by one of the AMTUs or an identified linkage-to-care partner and work as clinical staff or a case-manager or is a person familiar to linkage to care; or persons involved in posttest counseling and linkage-to-care processes. Clinical staff and case managers are chosen based on direct experience in the assistance of HIV seropositive youth obtaining medical care. This definition includes, but is not limited to, physicians, nurses, psychologists, social workers, and case managers (who may have diverse professional backgrounds).
•Component 3: All AMTU sites will be included.

Exclusion Criteria

•Component 1: No a priori exclusions.
•Component 2: No a priori exclusions.
•Component 3: No a priori exclusions.

Related studies

Thinking and Memory Problems in People With HIV

NCT01875588 · HIV Positive

RECRUITINGPhase 4

Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care

NCT06598397 · Human Immunodeficiency Virus (HIV), Smoking Cessation

Expanded Social Network Recruitment to HIV Testing (E-SNRHT) Intervention to Locate Undiagnosed Cases and Reduce HIV-related Stigma

NCT06857071 · Undiagnosed HIV Infection, Populations That Are Reluctant to Test for HIV, and more

SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Immigrant Families

NCT06627764 · Substance Abuse, Intimate Partner Violence (IPV), and more

Integrating Sexual Pleasure Into Harm Reduction Services for Men Who Have Sex With Men and Transgender Persons Who Engage in Chemsex or Substance Use in Thailand

NCT07509853 · HIV Prevention, Substance Use, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 28, 2017Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment35

Start dateMar 2008

Last updatedFeb 28, 2017

Condition

Locations shown

Children's National Medical Center

Washington D.C., District of Columbia

Childrens Diagnostic&Treatment Center

Fort Lauderdale, Florida

University of Miami School of Medicine

Miami, Florida

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 28, 2017Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions